INR100 UCLA Medical
Plaza, Suites 205-210 Los Angeles, California 90095 (310) 824-6199
Edward Tobinick MD, Medical DirectorReturn to Home PageCall (310) 824-6199 to
schedule your consultation todayDisclaimer:
Individual results vary. Anti-TNF treatment for the indications
below is off-label. Please see the Legal Disclaimer. The videos below depicts
an actual patient of the INR who has been treated for severe disc-related
pain. More than one dose may be necessary for optimal effect.
Some patients do not respond.Before
and After Videos:Video1Video2Video3Video4Video5 Video 6Video
7Video 8Video 9Video
10Video 9: Rapid relief
after 25 years of back pain following the first dose of the patented
perispinal etanercept treatment at the INR.
Video length 4:16 minutes.
Filmed 2009.
*See Tobinick, E., Perispinal
etanercept for neuroinflammatory disordersDrug Discovery
Today 2009 Feb;14(3-4):168-77; Tobinick, E. and S. Davoodifar,
Efficacy of etanercept delivered by perispinal administration
for chronic back and/or neck disc-related pain: a study of clinical
observations in 143 patients. Curr Med Res Opin, 2004. 20(7):
p. 1075-85; Tobinick, E.L. and S. Britschgi-Davoodifar, Perispinal
TNF-alpha inhibition for discogenic pain. Swiss Med Wkly,
2003. 133(11-12): p. 170-7.
Institute for Neurological
Research, a private
medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095